Tailorable PC71BM Isomers: Using the Most Prevalent Electron Acceptor to Obtain High‐Performance Polymer Solar Cells

Despite being widely used as electron acceptor in polymer solar cells, commercially available PC₇₁BM (phenyl‐C₇₁‐butyric acid methyl ester) usually has a “random” composition of mixed regioisomers or stereoisomers. Here PC₇₁BM has been isolated into three typical isomers, α‐, β₁‐ and β₂‐PC₇₁BM, to establish the isomer‐dependent photovoltaic performance on changing the ternary composition of α‐, β₁‐ and β₂‐PC₇₁BM. Mixing the isomers in a ratio of α/β₁/β₂=8:1:1 resulted in the best power conversion efficiency (PCE) of 7.67 % for the polymer solar cells with PTB7:PC₇₁BM as photoactive layer (PTB7=poly[[4,8‐bis[(2‐ethylhexyl)oxy]benzo[1,2‐b:4,5‐b′]dithiophene‐2,6‐diyl][3‐fluoro‐2‐[(2‐ethylhexyl)carbonyl]thieno[3,4‐b]thiophenediyl]]). The three typical PC₇₁BM isomers, even though sharing similar LUMO energy levels and light absorption, render starkly different photovoltaic performances with average‐performing PCE of 1.28–7.44 % due to diverse self‐aggregation of individual or mixed PC₇₁BM isomers in the otherwise same polymer solar cells.     

Comment on: “Topology identification and adaptive synchronization of uncertain complex networks with adaptive double scaling functions” [Commun Nonlinear Sci Numer Simul 2011;16:3337-43]

In this comment letter we point out that the main result of the recent paper [Xu Y, Zhou W, Fang J, Sun W. Topology identification and adaptive synchronization of uncertain complex networks with adaptive double scaling functions. Commun Nonlinear Sci Numer Simul 2011;16(18):3337-43] has certain errors. The mistakes are corrected and a correct version is presented in this letter. We further indicate that a sufficient condition has been neglected in a series of articles discussing the same topic of network topology identification; hence we hope this letter can help clarify some unclear concepts about this topic.     

Designing and Characterization of Biodegradable Multiblock Poly(L-Lactic Acid)/Polybutadiene Elastomers

A series of poly(L-lactic acid)/polybutadiene (PLA/PB) biodegradable multiblock elastomers was synthesized and characterized. A two-step process to prepare PLA/PB multiblock elastomers was applied. Melt polymerization was used to prepare poly(L-lactic acid) (PLA) terminated with hydroxyl groups and, at the same time, hydroxyl-terminated polybutadiene (HTPB) and 1,6-hexamethylene diisocyanate (HDI) were employed to synthesize diisocyanate-terminated polybutadiene (ITPB). Then, PLA and ITPB were reacted with different PLA/PB weight ratios. Consequently, a series of PLA/PB biodegradable poly(ester-urethane)s with crosslinked chains was obtained. Swelling characteristics and crosslink density of the crosslinked elastomer were investigated. DMA was applied to characterize its thermal properties. The measurement of mechanical properties showed that a PLA/PB elastomer with adjustable mechanical properties was synthesized. Micromorphology, hydrophobicity, and degradability of the material were also characterized.     

Development of an LC/MS/MS method in order to determine arctigenin in rat plasma: its application to a pharmacokinetic study

In this study, a simple and sensitive LC/MS/MS method was developed and validated for the determination of arctigenin in rat plasma. The MS detection was performed using multiple reaction monitoring at the transitions of m/z 373.2 → 137.3 for arctigenin and m/z 187.1 → 131.0 for psoralen (internal standard) with a Turbo IonSpray electrospray in positive mode. The calibration curves fitted a good linear relationship over the concentration range of 0.2–500 ng/mL. It was found that arctigenin is not stable enough at both room temperature and ?80 °C unless mixed with methanol before storage. The validated LC/MS/MS method was successfully applied for the pharmacokinetic study of arctigenin in rats. After intravenous injection of 0.3 mg/kg arctigenin injection to rats, the maximum concentration, half‐life and area under the concentration–time curve were 323 ± 65.2 ng/mL, 0.830 ± 0.166 and 81.0 ± 22.1 h ng/mL, respectively. Copyright © 2013 John Wiley & Sons, Ltd.